EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Corrigendum to ’ Phase 1 clinical trial on Orgasmic Meditation (OM): Assessing safety and feasibility as a meditation practice for individuals with PTSD’[Contemporary Clinical Trials Communications 45 (2025) 101451]

Daniel Kriegman, Rachel Pelletier, Caroline Griggs, Caryn Roth

Contemporary Clinical Trials Communications · 2026-11 · 101709

DOI: 10.1016/j.conctc.2026.101709 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Contemporary Clinical Trials Communications, 2026-11. Verfasst von Daniel Kriegman und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kriegman, D., Pelletier, R., Griggs, C., & Roth, C. (2026). Corrigendum to ’ Phase 1 clinical trial on Orgasmic Meditation (OM): Assessing safety and feasibility as a meditation practice for individuals with PTSD’[Contemporary Clinical Trials Communications 45 (2025) 101451]. Contemporary Clinical Trials Communications, 101709. https://doi.org/10.1016/j.conctc.2026.101709

Vancouver

Kriegman D, Pelletier R, Griggs C, Roth C. Corrigendum to ’ Phase 1 clinical trial on Orgasmic Meditation (OM): Assessing safety and feasibility as a meditation practice for individuals with PTSD’[Contemporary Clinical Trials Communications 45 (2025) 101451]. Contemporary Clinical Trials Communications. 2026:101709. doi:10.1016/j.conctc.2026.101709

BibTeX
@article{Kriegman2026,
  author = {Kriegman, Daniel and Pelletier, Rachel and Griggs, Caroline and Roth, Caryn},
  title = {Corrigendum to ’ Phase 1 clinical trial on Orgasmic Meditation (OM): Assessing safety and feasibility as a meditation practice for individuals with PTSD’[Contemporary Clinical Trials Communications 45 (2025) 101451]},
  journal = {Contemporary Clinical Trials Communications},
  year = {2026},
  pages = {101709},
  doi = {10.1016/j.conctc.2026.101709}
}
Kostenlos starten →